Post by
LouisW on Jun 03, 2023 9:43am
poster
https://www.theratech.com/medicines-pipeline/pipeline-and-science/oncology/scientific-papers
Comment by
Trogarzon on Jun 03, 2023 12:07pm
Any comments on this bunch of Chinese data.
Comment by
muslix1 on Jun 03, 2023 5:03pm
and no news for ASCO 2023 meeting....good or not please good week-end
Comment by
Lee430 on Jun 04, 2023 9:06am
Is there any sinificance to this name assigned to TH1902? Idont recall it being used before. Sudocetaxel zendusortide (TH1902)
Comment by
SPCEO1 on Jun 04, 2023 10:42am
No, it is just the normal procedure to give a drug progressing through FDA trials an unpronounceable name. Later it's name will change again if it is approved to something slightly less unpronounceable!